©The Author(s) 2025.
World J Transplant. Dec 18, 2025; 15(4): 105621
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.105621
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.105621
Table 5 Diagnostic tests for cardiovascular disease detection in liver transplant candidates
| Diagnostic test | Purpose | Risk stratification | Key clinical parameters |
| Stress echocardiography | Assesses myocardial function under stress conditions to detect ischemia and evaluate contractile reserve | Low risk: Normal stress echocardiography findings. High risk: Inducible ischemia or significant wall motion abnormalities | Utilizes exercise or pharmacologic agents to induce stress. Non-invasive functional assessment. May have limitations in cirrhotic patients due to hyperdynamic circulation leading to false-negative results |
| Myocardial perfusion scintigraphy (nuclear stress test) | Evaluates myocardial perfusion at rest and under stress to identify areas of reduced blood flow, aiding in the detection of silent ischemia | Low risk: No perfusion defects; High risk: Reversible perfusion defects indicating ischemia | Involves administration of radioactive tracers. Non-invasive imaging technique. Accuracy may be compromised in cirrhotic patients due to splanchnic vasodilation and hyperdynamic circulation |
| CCTA | Provides detailed anatomical visualization of coronary arteries to detect obstructive CAD | Low risk: No or minimal coronary artery disease. High risk: Presence of significant coronary artery stenosis | High-resolution imaging modality. Non-invasive anatomical assessment. Effective in detecting CAD in LT candidates |
| CAC scoring | Quantifies the burden of coronary artery calcification to stratify cardiovascular risk | Low risk: CAC score of 0. Moderate risk: CAC score 1-100. High risk: CAC score > 100 | Derived from CCTA or dedicated calcium scoring CT. Non-invasive quantification of calcified plaque. Higher scores associated with increased risk of perioperative MACE |
| Cardiac MRI | Provides detailed images of cardiac structures and function, aiding in the assessment of myocardial viability, fibrosis, and overall cardiac function | Low risk: Normal cardiac MRI findings; High risk: Presence of myocardial fibrosis, reduced ejection fraction, or other significant abnormalities | Offers high spatial resolution images without ionizing radiation. Superior tissue characterization capabilities. Useful in detecting myocardial fibrosis and assessing ventricular function. Limited availability and higher cost may restrict widespread use |
- Citation: Lulic I, Lulic D, Durekovic I, Pavicic Saric J, Bacak Kocman I, Sarec Z, Rogic D. YKL-40: Revolutionizing cardiac risk prediction and therapy in liver transplantation. World J Transplant 2025; 15(4): 105621
- URL: https://www.wjgnet.com/2220-3230/full/v15/i4/105621.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i4.105621